You are sitting at the far end of a conference table in a two-story office building off the 101, in one of those mid-Peninsula office parks where a hundred-person semiconductor company can sit next to a multi-billion-dollar venture fund and the only difference is the size of the sign out front. The room is spare. No art. A whiteboard still carries the ghost of last quarter's projections, half-erased.
The head of finance is presenting. She is walking the board through a spreadsheet projected on the far wall. Three thousand patent files, organized by internal reference number, color-coded by status. Green means current. Yellow means thirty days out. Red means urgent. She has spent four months building this tracker, and it shows.
The two board members dialing in from San Francisco and Zurich are small rectangles on a wall-mounted monitor. The executives in the room have laptops open. You have a legal pad, bad posture, and the quiet resignation of someone who should have called this meeting months ago.
The company is Verada Semiconductor. A hundred and forty people designing AI-accelerated inference chips for the two or three customers whose names you would recognize from earnings calls. The company's entire enterprise value lives in its patent portfolio. And right now, a finance executive is presenting that portfolio to a board that does not know the difference between a filing tracker and a prosecution strategy.
She finishes. She looks at the CEO. He nods. "We have visibility," she says. "We are monitoring closely. We understand what needs to get done and when."
The board is reassured. You are not.
Six weeks earlier, the partner at the company's outside patent firm called. She had built this portfolio from the ground up over four years. Sixty active matters. Chip architecture, on-chip memory designs, a novel inference engine that several larger players had already noticed. That attention was not a compliment. It was a threat posture. Two of those larger players had already filed challenges against its patents. They had nine-figure litigation budgets and institutional patience. Verada had neither.
What Verada also did not have was the ability to pay its patent lawyers.
The Series B had been raised at the peak of AI enthusiasm. The burn rate was built around landing a major customer by Q3. Q3 came and went. For months, the company managed cash week to week, and the patent firm's invoices aged with everything else. Every month you heard the same thing. Funding was around the corner. When it arrived, the firm would be paid first.
So you waited. Outside counsel had managed the portfolio from the start, and the partner was someone you trusted. Calling the board in meant a special meeting, with proper notice, to report a problem that management said was about to solve itself. Each month it was easy to give it one more month.
The firm ran out of patience before the funding showed up. The IP partner did not call the CEO. She called you. In the careful language of one lawyer speaking to another, she said they had come to the end of the rope. The files would be transferred within thirty days. The representation was over.
Now the gap was real. And the head of finance had stepped into it with a spreadsheet.
A spreadsheet tells you when something is due. It does not tell you what to do about it.
You wait until the board's initial questions are finished. The questions are soft. How many matters are active. Whether the foreign associates have been contacted. Whether there is a timeline. The head of finance handles them well. She is prepared for what she was prepared for.
Then you ask your question.
"What is our prosecution strategy for the European office action on the inference engine architecture?"
She checks the spreadsheet. "That one is flagged yellow. Sixty days out."
"I know when it is due. I am asking what we are going to do about it. Whether we contest the examiner's claim construction. Whether we file a divisional. What our theory is for protecting the broadest claims without creating estoppel problems in other jurisdictions."
The room goes quiet. The administrative silence of people realizing that the conversation just changed categories. The CEO looks at his laptop. The board member in San Francisco leans forward in his rectangle.
You are not trying to embarrass anyone. Lawyers learn a framework in their first year of law school called IRAC. Issue, Rule, Application, Conclusion. The entire discipline lives in the third step: Application. That is where you ask why. That single word, repeated patiently, is the difference between describing a problem and solving one.
You ask the next question. She has told the board that some filings are being allowed to lapse deliberately. "Focusing on critical markets," she said. You ask which filings have been abandoned and on what basis.
The answer is where the quiet resignation settles into your chest. Several abandoned filings had years of remaining patent life. She looked at the titles and made judgments about which markets mattered. But a patent title tells you the subject of the application. The claims tell you what you own. Those are different things. Letting a filing lapse because a market seems unimportant today can also cut off the later filings that depend on it, the continuations and divisionals a company uses to widen its protection. Some of those doors do not reopen. She has been making irreversible decisions about the company's most valuable assets using criteria that had nothing to do with the assets' actual scope.
A patent title tells you the subject of the application. The claims tell you what you own. Those are different things.
Each lost claim is a building block pulled from the wall. And nobody on the board knows it is happening, because the spreadsheet shows green.
You request a closed session. General counsel and directors only. As general counsel and corporate secretary, you can ask for one when fiduciary obligations are at issue, and the executives in the room know it. The CEO glances at the head of finance. She gathers her laptop. The door closes.
You present three findings to the board. You do not use the spreadsheet.
The patent firm withdrew because its invoices went unpaid for too long. The head of finance filled the gap with a tracking spreadsheet and has been making prosecution decisions without patent counsel. Filings with years of remaining life have been abandoned based on market assumptions rather than claim analysis. Some of those decisions cannot be reversed. The board was told the situation was under control. The spreadsheet supported that impression. The underlying reality does not.
You are careful. You do not accuse anyone of anything. What you describe is common and dangerous: a competent person doing real work on the wrong problem, performing for an audience that cannot tell the difference. The spreadsheet is useful as an organizational tool. But an organizational tool is not a legal strategy. Tracking deadlines is not managing prosecution. And the board's fiduciary duty runs to the outcome, not to the effort.
The board member in Zurich unmutes. "What do you recommend?"
Three things. Retain specialized patent counsel immediately, even on a limited engagement, to triage the portfolio. Conduct a claim-by-claim review of the active matters to determine actual scope of protection, not just filing status. And establish a protocol so that any changes to the patent portfolio, intentional or otherwise, are reported to both management and the board as material events.
The board adopts all three. Within two weeks, specialized counsel is retained. The review identifies four filings abandoned in error, two of which are reinstated within the grace period. The claim analysis reveals that Verada's inference engine patents are broader than anyone had realized, which becomes a significant factor in the customer negotiation that closes three months later.
After the meeting, the head of finance stops you in the hallway. She is not happy. She spent four months on that spreadsheet. She tracked every deadline. She contacted every foreign associate. She worked hard. She wants you to know that.
You tell her you know. You mean it. Then you tell her something she does not want to hear. In corporate governance, the legal standard is not "did you try?" It is "did you act with the care that a reasonably prudent person would exercise under similar circumstances?" A reasonably prudent person would not have made prosecution decisions without a patent attorney. That question requires no specialized expertise. It requires the willingness to ask it.
She walks away. You stand in the hallway for a moment and think it through. The most dangerous problems in a company are the ones that are visible, organized, color-coded, and maintained with great discipline.
Every significant failure I have observed in twenty-five years of corporate practice shares one feature. Somewhere in the story, there is a person who worked very hard at something that did not need to be done. And nobody asked why.
I include myself. For months, I worked hard at waiting. Funding was around the corner. Outside counsel had the portfolio. A special meeting needs notice, and I would have been calling it to report a problem management said was about to solve itself. Each month, one more month seemed reasonable. The board's duty runs to the outcome, and so did mine. I should have called that meeting long before the firm called me.